Thrombosis occurs after aortopulmonary shunting in children despite the use of heparin and oral antiplatelet agents. We describe the use of an intravenous antiplatelet agent for secondary prevention of shunt thrombosis without adverse events. Platelet mapping was used to monitor the effects and demonstrated the rapid onset of platelet inhibition.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.athoracsur.2015.02.103 | DOI Listing |
Publication Analysis
Top Keywords
secondary prevention
8
prevention shunt
8
shunt thrombosis
8
intravenous gpiib/iiia
4
gpiib/iiia inhibitor
4
inhibitor secondary
4
thrombosis pediatric
4
pediatric patient
4
patient thrombosis
4
thrombosis occurs
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!